Abha Kundi*’s Insights

15 total results. Page 1 of 2.

Health Care Counsel Blog
CMS ACCESS Model Update: Payment Rates and Performance Targets Released for 2026–2027
Longevity Lens
The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies
Longevity Lens
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss
Longevity Lens
ArentFox Schiff Launches First-of-Its-Kind Longevity & Healthspan Industry Group
Alerts
Model Behavior: FDA and EMA’s Guide to Good AI in Drug Development
Alerts
FDA Issues Updated Guidance on Low-Risk General Wellness Devices and Clinical Decision Support Software
Alerts
A Wrinkle in the Supply Chain: FDA’s First DSCSA 483 for a Dispenser
Longevity Lens
Staying on TEMPO: Five Things for Digital Health Companies to Know About the FDA’s New Pilot
Longevity Lens
Whoop There It Is: FDA Warning Letter Now Anchors a Class Action Against Whoop
Alerts
Top Four FDA Compliance Issues for Hospitals and Health Systems: What They Are, Why They Matter, and What To Watch
Alerts
Safe Chain Shows the DSCSA Is a Compliance Mandate and a Criminal Boundary
Alerts
FDA Issues Guidance on Alternative Tools for Assessing Drug Manufacturing Facilities in Pending Applications